Mutation analysis of gonadotropin receptor and G protein genes in various types of human ovarian tumors

Japanese Journal of Clinical Oncology

Volumn 26, Issue 5, 1996, Pages 298-302

  Ichikawa, Yoshihito ^a   Yoshida, Sadao ^a   Suzuki, Hiromichi ^a   Nishida, Masato ^a   Tsunoda, Hajime ^a   Kubo, Takeshi ^a   Miwa, Masanao ^a   Uchida, Kazuhiko ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

G protein; Gonadotropin receptor; Mutation; Ovarian tumor

Indexed keywords

FOLLITROPIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LUTEINIZING HORMONE RECEPTOR;

ARTICLE; CELL CULTURE; FEMALE; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; POINT MUTATION; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

FEMALE; GTP-BINDING PROTEINS; HUMANS; OVARIAN NEOPLASMS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, FSH; RECEPTORS, LH; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0030266415     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jjco.a023236     Document Type: Article

References (17)

1. Whittemore AS, Harris R, Itnyre J: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II: invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136: 1184-1203, 1992
2. Willemsen W, Kruitwagen R, Bastiaans B, Hanselaar T, Rolland R: Ovarian stimulation and granulosa-cell tumour. Lancet 341: 986-988, 1993
3. Simon WE, Albrecht M, Dietel M, Holzel F: Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 70: 839-845, 1983
4. Simon MI, Strathmann MP, Gautman N: Diversity of G proteins in signal transduction. Science 252: 802-808, 1991
5. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G: Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649-651, 1993
6. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr: A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365: 652-654, 1993
7. Lyons J, Landis CA, Harsh G, Vallar L, Grünewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, McCormick F: Two G protein oncogenes in human endocrine tumors. Science 249: 655-659, 1990
8. Kiyozuka Y, Noda T, Maruyama M, Adachi S, Ichijo M, Maeda H, Morimoto J, Imai S: Establishment and characterization of CA125 and TPA producing human ovarian serous cystadenocarcinoma cell line (SHIN-3). Hum Cell 1: 334-335, 1988 (in Japanese)
9. Nishida M, Iwasaki H: Establishment of a human ovarian clear cell carcinoma cell line (HAC-2 cells) in vitro. Hum Cell 1: 345-346, 1988 (in Japanese)
10. Morisawa T, Kuramoto H, Shimoda T, Hamano M, Kato Y, Hata H: Establishment and characterization of a CA-125 producing cell line (OVAS-21) from a clear cell adenocarcinoma of the ovary. Hum Cell 1: 347, 1988 (in Japanese)
11. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 1989
12. Suzuki Y, Sekiya T, Hayashi K: Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants. Anal Biochem 192: 82-84, 1991
13. Stadel BV: The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 123: 772-774, 1975
14. Cramer DW, Welch WR: Determinants of ovarian cancer risk. II: inferences regarding pathogenesis. J Natl Cancer Inst 71: 717-721, 1983
15. Miller DS, Teng NN, Ballon SC: Epithelial ovarian carcinoma in patients with intersex disorders: the role of pituitary gonadotropins in ovarian tumorigenesis. Gynecol Oncol 24: 299-308, 1986
16. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L: GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692-696, 1989
17. 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci USA 88: 11354-11358, 1991